Long Focus Capital Management, LLC - VINCERX PHARMA INC ownership

Quarter-by-quarter ownership
Long Focus Capital Management, LLC ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q3 2023$1,109,741
-22.3%
1,098,7530.0%0.04%
-38.5%
Q2 2023$1,428,379
-2.9%
1,098,753
-22.3%
0.06%
-21.7%
Q1 2023$1,471,549
+2.0%
1,414,9510.0%0.08%
-17.0%
Q4 2022$1,443,250
-1.5%
1,414,951
+33.3%
0.10%
-30.1%
Q3 2022$1,465,000
+13.2%
1,061,505
+8.3%
0.14%
+5.1%
Q2 2022$1,294,000
-24.8%
980,000
+127.8%
0.14%
-38.5%
Q1 2022$1,721,000
+20.4%
430,200
+206.8%
0.22%
+16.9%
Q4 2021$1,429,000140,2030.19%
Other shareholders
VINCERX PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,658,199$2,189,0000.84%
Affinity Asset Advisors, LLC 1,374,098$1,814,0000.76%
SABBY MANAGEMENT, LLC 500,559$661,0000.45%
TANG CAPITAL MANAGEMENT LLC 1,030,634$1,360,0000.21%
Rubric Capital Management LP 2,107,000$2,781,0000.15%
Long Focus Capital Management, LLC 980,000$1,294,0000.14%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$508,0000.09%
Clearline Capital LP 452,184$597,0000.08%
Sio Capital Management, LLC 102,049$135,0000.05%
Rock Springs Capital Management LP 814,194$1,075,0000.03%
View complete list of VINCERX PHARMA INC shareholders